Understanding how specific proteins affect the survival and activation of immune cells

The Role of Pacs1-Wdr37 inLymphocyte Quiescence and Survival

['FUNDING_R01'] · UT SOUTHWESTERN MEDICAL CENTER · NIH-11005692

This study is looking at how two proteins, Pacs1 and Wdr37, help keep immune cells called lymphocytes in balance, which is important for fighting off illnesses, and it could lead to better treatments for autoimmune diseases and certain cancers.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUT SOUTHWESTERN MEDICAL CENTER (nih funded)
Locations1 site (DALLAS, UNITED STATES)
Trial IDNIH-11005692 on ClinicalTrials.gov

What this research studies

This research investigates the role of two proteins, Pacs1 and Wdr37, in maintaining the balance between quiescence and activation of lymphocytes, which are crucial immune cells. By studying how these proteins influence lymphocyte survival and response to signals, the research aims to uncover mechanisms that could lead to better treatments for immune-related conditions. The approach involves examining the effects of these proteins on B and T cells in laboratory settings, including their responses to stress and activation signals. Insights gained could help in understanding autoimmune diseases and lymphoid malignancies.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research include individuals with autoimmune disorders or lymphoid malignancies.

Not a fit: Patients with unrelated health conditions or those not affected by immune system disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating autoimmune diseases and certain types of blood cancers by targeting the mechanisms of lymphocyte survival.

How similar studies have performed: Previous research has shown promising results in understanding lymphocyte behavior and survival, suggesting that this approach could yield valuable insights.

Where this research is happening

DALLAS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.